Dhruv Kazi, MD, MSc, MS, discusses his new study that examines the costs of PCSK9 inhibitors to treat high cholesterol.
Cost-effectiveness Analysis of New Cholesterol Drug
Dhruv Kazi, MD, MSc, MS, discusses his new study that examines the costs of PCSK9 inhibitors to treat high cholesterol.
![asmr Sleeping with your girlfriend [soft-breathing] [no talking] [no heartbeat sound]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_t9-HwvhwXSpKlWi5v50xHWRIniSD2LawWmwExZt9xBUG6VDaQHgEuArsiSJKGGvXO8Ms6SMTzUeQubbQKYaVOnaiUy4B0kTYzUjzs-bM5uqurf_Q=w680)
0 Comments